3140 results for «238»
3140 results
Innovation never stops: Cardiovalve in action!
24 Nov 2024 – From PCR London Valves 2024
Join us as we explore the latest advancements in transcatheter tricuspid valve replacement technologies. This session develops the anatomical and imaging challenges associated with this rapidly developing clinical field and provides an update on the Cardiovalve tricuspid clinical program, illustrated by a recorded case.
RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation
25 Nov 2024 – From PCR London Valves 2024
Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how...
TAVI for pure aortic regurgitation with a dedicated CE-mark device: an underdiagnosed and undertreated disease
26 Nov 2024 – From PCR London Valves 2024
Explore this session to learn about the unmet needs in aortic regurgitation (AR) and the performance of dedicated TAVI devices for AR. Discover why new thresholds for severe AR are necessary, and how traditional methods may underestimate its severity. Gain insights into the TRILOGY THV system,...
From index procedure to re-valving with a novel self-expanding valve
25 Nov 2024 – From PCR London Valves 2024
Watch this simulation-based symposium to explore the value of the Index Procedure in achieving optimal outcomes during the initial implant, crucial for preventing paravalvular leak, pacemaker dependency, and ensuring precise commissural alignment for coronary access. Discover how the ACURATE neo2/PRIME offers excellent coronary access with its...
A window into the future - Expanding horizons for patients with long life expectancy with the Evolut FX + TAVI system
25 Nov 2024 – From PCR London Valves 2024
Gain insights into the key considerations when performing TAVI in patients with long life expectancy, including long-term outcomes, valve durability, and the feasibility of future redo-TAVI. Discover the latest data on TAVI in women and patients with small annulus anatomy, as well as a live case...
Transforming interventional care for patients with mitral regurgitation: simulation and case-based learning
26 Nov 2024 – From PCR London Valves 2024
Explore the differentiating features of the PASCAL Precision system for the treatment of patients with mitral regurgitation through simulation and case-based learning.
Tailoring tricuspid interventions with the EVOQUE and PASCAL Precision systems
25 Nov 2024 – From PCR London Valves 2024
Catch up on this engaging session, featuring a parallel case study of two high-risk patients with severe tricuspid regurgitation. Discover how the PASCAL system is used to treat diverse TR anatomies and explore patient selection and management strategies for the EVOQUE system. Watch a recorded case...
The many faces of complex TAVI
25 Nov 2024 – From PCR London Valves 2024
Learn how to navigate challenging cases illustrating the complexities of TAVI procedures and the importance of device selection and implantation technique. Discover strategies for tackling issues like bicuspid aortic stenosis, difficult access, and complex anatomies.
Pushing the boundaries to optimise patient outcomes: from planning to success
26 Nov 2024 – From PCR London Valves 2024
Learn from experts about achieving optimal TAVI outcomes, tailoring approaches for lifetime management, and mastering tips for diverse anatomical challenges.
TAVR implantation techniques: are they the same for all self-expanding TAV platforms?
25 Nov 2024 – From PCR London Valves 2024
Explore the differences between currently available self-expanding TAVI platforms and how they influence device selection and procedural techniques. A panel of experts discuss the pros and cons of these platforms and valuable tips and tricks to tackle various anatomical challenges effectively.
Zero-contrast TAVI while using a novel full-body embolic protection filter
26 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in zero-contrast TAVI through this case-based session. Learn when to consider a zero-contrast protocol, gain practical insights on performing the procedure, and explore a novel full-body embolic protection filter designed to enhance safety during transcatheter interventions.
Mastering structural heart intervention with innovations in imaging
25 Nov 2024 – From PCR London Valves 2024
Explore the future of transcatheter mitral and tricuspid therapies in this innovative session. Learn how advanced imaging techniques like CT/fluoro fusion and 4D intracardiac echocardiography are revolutionizing complex procedures, enhancing both safety and outcomes. Hear from experienced operators as they share their insights on the evolving...
A dedicated TAVI valve for aortic regurgitation: the J-VALVE solution
26 Nov 2024 – From PCR London Valves 2024
Discover the 30-day outcomes of the novel transfemoral J-VALVE solution, a dedicated TAVI device designed specifically for the treatment of aortic regurgitation. Understand its unique automatic anchoring mechanism and the remarkable left ventricular remodelling it can facilitate.
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
25 Nov 2024 – From PCR London Valves 2024
Through the presentation of several compelling cases, including an 88-year-old male with CKD, RBBB, moderate LV dysfunction, and severe aortic stenosis, a Type 1a bicuspid native AS, and an extraordinary TAVI in an 83-year-old with acute heart failure and comorbidities, this session will dive into the...
New frontiers in TAVI: have we reached them?
25 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in TAVI as we look into the results of the EARLY TAVR and RHEIA trials. Explore how these groundbreaking findings may influence clinical practice guidelines and shape the future of TAVI, as well as the remaining unmet clinical needs in TAVI.
Cinch it if you can - Indirect annuloplasty for functional mitral regurgitation
25 Nov 2024 – From PCR London Valves 2024
This session on mitral regurgitation offers an in-depth look at the EMPOWER trial outcomes, indirect annuloplasty in aFMR, and remodeling with the CARILLON device. Explore the benefits of early treatment for secondary mitral regurgitation, understand the role of left ventricular reverse remodeling, and review the latest...
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction
03 Apr 2022
Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial
09 Nov 2022
Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.
Author
